Literature DB >> 12775722

Differential requirement of SWI/SNF for androgen receptor activity.

Thomas W Marshall1, Kevin A Link, Christin E Petre-Draviam, Karen E Knudsen.   

Abstract

The androgen receptor (AR) is a ligand-dependent transcription factor whose activity is required for prostate cancer proliferation. Because ablation of AR activity is a critical goal of prostate cancer therapy, much emphasis has been placed on understanding the accessory proteins that regulate AR function in the prostate. Several co-activators have been shown to be required for full AR activity, including histone acetyl-transferases and TRAP/mediator complexes. SWI/SNF comprises a family of large, multisubunit complexes present in the cell, which contain one of two core ATPases required for nucleosome re-positioning, BRG1 or hBRM. We investigated the specific requirement of the SWI/SNF core ATPases for AR function. Using cells deficient in both BRG1 and hBRM, we show that activation of one AR target promoter, prostate-specific antigen (PSA), requires SWI/SNF chromatin remodeling for activity. A second AR target promoter, probasin, maintained a low level of activation in the absence of SWI/SNF. AR stimulation on the probasin core promoter could be partially induced with BRG1, but hBRM strongly stimulated AR activity. The PSA promoter was only induced by the restoration of hBRM. In contrast, ligand-dependent activation of the estrogen receptor was equally stimulated by BRG1 or hBRM. We demonstrate that the addition of a known enhancer region to the core PSA promoter bypasses the requirement for SWI/SNF on the PSA promoter, indicating that elements upstream of specific proximal promoters can impact the influence of the SWI/SNF complex on target gene activation. Addition of the enhancer to the probasin core promoter failed to impact the SWI/SNF requirement. In summary, SWI/SNF function potently regulates core AR target gene promoter activation, with a preference for hBRM-containing complexes. These studies highlight a role for the enhancer in altering the impact of SWI/SNF action and suggest a disparity in AR target genes for SWI/SNF requirement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775722     DOI: 10.1074/jbc.M304582200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Androgen modulation of coregulator expression in prostate cancer cells.

Authors:  Hannelore V Heemers; Kevin M Regan; Lucy J Schmidt; S Keith Anderson; Karla V Ballman; Donald J Tindall
Journal:  Mol Endocrinol       Date:  2009-01-22

2.  Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.

Authors:  Aanchal Mehrotra; Srinivas Vinod Saladi; Archit R Trivedi; Shweta Aras; Huiling Qi; Ashika Jayanthy; Vijayasaradhi Setaluri; Ivana L de la Serna
Journal:  Arch Biochem Biophys       Date:  2014-07-12       Impact factor: 4.013

3.  Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.

Authors:  Geetha V Rayasam; Cem Elbi; Dawn A Walker; Ronald Wolford; Terace M Fletcher; Dean P Edwards; Gordon L Hager
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.

Authors:  Kevin A Link; Craig J Burd; Erin Williams; Thomas Marshall; Gary Rosson; Erin Henry; Bernard Weissman; Karen E Knudsen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer.

Authors:  Hui Shen; Nathan Powers; Nitin Saini; Clay E S Comstock; Ankur Sharma; Katherine Weaver; Monica P Revelo; William Gerald; Erin Williams; Walter J Jessen; Bruce J Aronow; Gary Rosson; Bernard Weissman; Christian Muchardt; Moshe Yaniv; Karen E Knudsen
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 6.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

7.  2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.

Authors:  Supriya Shah; Janet K Hess-Wilson; Siobhan Webb; Hannah Daly; Sonia Godoy-Tundidor; Jae Kim; Joanne Boldison; Yehia Daaka; Karen E Knudsen
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

8.  Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.

Authors:  Dennis J van de Wijngaart; Hendrikus J Dubbink; Michel Molier; Carola de Vos; Jan Trapman; Guido Jenster
Journal:  Mol Endocrinol       Date:  2009-09-17

9.  Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers.

Authors:  Harri Makkonen; Miia Kauhanen; Ville Paakinaho; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Nucleic Acids Res       Date:  2009-05-11       Impact factor: 16.971

10.  Two chromatin remodeling activities cooperate during activation of hormone responsive promoters.

Authors:  Guillermo Pablo Vicent; Roser Zaurin; A Silvina Nacht; Ang Li; Jofre Font-Mateu; Francois Le Dily; Michiel Vermeulen; Matthias Mann; Miguel Beato
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.